Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)
China · Delayed Price · Currency is CNY 6.84
+0.08 (1.18%)
At close: Feb 4, 2026
SHE:002412 Revenue
Hunan Hansen Pharmaceutical had revenue of 231.94M CNY in the quarter ending September 30, 2025, with 8.62% growth. This brings the company's revenue in the last twelve months to 1.05B, up 8.90% year-over-year. In the year 2024, Hunan Hansen Pharmaceutical had annual revenue of 1.00B with 5.12% growth.
Revenue (ttm)
1.05B
Revenue Growth
+8.90%
P/S Ratio
3.27
Revenue / Employee
627.63K
Employees
1,675
Market Cap
3.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.00B | 48.94M | 5.12% |
| Dec 31, 2023 | 955.53M | 39.47M | 4.31% |
| Jan 1, 2023 | 916.06M | 24.23M | 2.72% |
| Jan 1, 2022 | 891.84M | 150.60M | 20.32% |
| Dec 31, 2020 | 741.24M | -146.25M | -16.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guizhou Yibai Pharmaceutical | 1.91B |
| Henan Taloph Pharmaceutical Stock Co.,Ltd | 1.79B |
| Nanjing Well Pharmaceutical Group | 1.31B |
| Anhui Sunhere Pharmaceutical Excipients | 934.72M |
| Harbin Medisan Pharmaceutical | 874.60M |
| Jiangxi Synergy Pharmaceutical | 825.20M |
| Zhejiang Cheng Yi Pharmaceutical | 790.86M |
| Baotou Dongbao Bio-Tech Co.,Ltd | 784.62M |